GILMARTIN CAPITAL LLC
GILMARTIN CAPITAL LLC is a Seed, Series A, Series B and Series C+ fund in the US and Israel investing in Healthcare, healthcare-tech, medical-devices, life-science-tools and diagnostics.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, healthcare-tech, medical-devices, life-science-tools, diagnostics
- Invests in
- US-wide, Israel
- Actively investing
- Yes
- Founded
- 2021
- Website
- gilmartincap.com
Check size not disclosed
Thesis
Gilmartin Capital LLC is a venture capital firm established in 2021, specializing in transformative healthcare companies. Their investment thesis focuses on innovative solutions in medical devices, life science tools, diagnostics, and digital health that address significant unmet needs, accelerate scientific discovery, or improve care delivery. They target companies beyond the proof-of-concept stage, poised for growth, and primarily invest in the United States, with some activity in Israel. The firm engages with companies from seed to growth equity stages. The first fund, Gilmartin Capital Fund I, L.P., was oversubscribed at its first close in November 2021. Specific check sizes are not publicly disclosed, but their investment focus suggests a flexible approach to funding needs across various stages.
Common questions
Does GILMARTIN CAPITAL LLC invest at the Seed stage?
Yes. GILMARTIN CAPITAL LLC lists Seed, Series A, Series B and Series C+ among the stages it invests in.
Where does GILMARTIN CAPITAL LLC invest?
GILMARTIN CAPITAL LLC invests in the US and Israel.